0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acute Migraine Drugs Market Insights and Forecast to 2027
Published Date: June 2021
|
Report Code: QYRE-Auto-15T1655
Home | Market Reports | Health | Health Conditions | Pain Management
Global Acute Migraine Drugs Market Insights and Forecast to 2027

Global Acute Migraine Drugs Market Insights and Forecast to 2027

Code: QYRE-Auto-15T1655
Report
June 2021
114 Pages
QYResearch
Region: Global, Japan, India, North America, Middle East, Europe, Germany, France, South Korea, Australia, Philippines, Malaysia, Thailand, Indonesia, Turkey, Saudi Arabia, Taiwan, Italy,
Description
Table of Content
Tables & Figures
Acute Migraine Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

Triptans
NSAIDs
Others
The proportion of triptans in 2019 is about 79.59% market share.

Segment by Application

Hospital Pharmacies
Drug Stores
The proportion of hospitals in 2019 is about 62.93%.

BY COMPANY

GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
1 Study Coverage
1.1 Acute Migraine Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Acute Migraine Drugs Market Size Growth Rate by Type
1.4.2 Triptans
1.4.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Migraine Drugs Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Acute Migraine Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Acute Migraine Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Acute Migraine Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Acute Migraine Drugs Regions by Sales
2.4.1 Global Top Acute Migraine Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Acute Migraine Drugs Regions by Sales (2022-2027)
2.5 Global Top Acute Migraine Drugs Regions by Revenue
2.5.1 Global Top Acute Migraine Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Acute Migraine Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Acute Migraine Drugs Sales by Manufacturers
3.1.1 Global Top Acute Migraine Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Acute Migraine Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Acute Migraine Drugs Sales in 2020
3.2 Global Acute Migraine Drugs Revenue by Manufacturers
3.2.1 Global Top Acute Migraine Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Acute Migraine Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Acute Migraine Drugs Revenue in 2020
3.3 Global Acute Migraine Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Acute Migraine Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Acute Migraine Drugs Sales by Type
4.1.1 Global Acute Migraine Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Acute Migraine Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Acute Migraine Drugs Sales Market Share by Type (2016-2027)
4.2 Global Acute Migraine Drugs Revenue by Type
4.2.1 Global Acute Migraine Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Acute Migraine Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Acute Migraine Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Acute Migraine Drugs Price by Type
4.3.1 Global Acute Migraine Drugs Price by Type (2016-2021)
4.3.2 Global Acute Migraine Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Acute Migraine Drugs Sales by Application
5.1.1 Global Acute Migraine Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Acute Migraine Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Acute Migraine Drugs Sales Market Share by Application (2016-2027)
5.2 Global Acute Migraine Drugs Revenue by Application
5.2.1 Global Acute Migraine Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Acute Migraine Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Acute Migraine Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Acute Migraine Drugs Price by Application
5.3.1 Global Acute Migraine Drugs Price by Application (2016-2021)
5.3.2 Global Acute Migraine Drugs Price Forecast by Application (2022-2027)
6 North America
6.1 North America Acute Migraine Drugs Market Size by Type
6.1.1 North America Acute Migraine Drugs Sales by Type (2016-2027)
6.1.2 North America Acute Migraine Drugs Revenue by Type (2016-2027)
6.2 North America Acute Migraine Drugs Market Size by Application
6.2.1 North America Acute Migraine Drugs Sales by Application (2016-2027)
6.2.2 North America Acute Migraine Drugs Revenue by Application (2016-2027)
6.3 North America Acute Migraine Drugs Market Size by Country
6.3.1 North America Acute Migraine Drugs Sales by Country (2016-2027)
6.3.2 North America Acute Migraine Drugs Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Acute Migraine Drugs Market Size by Type
7.1.1 Europe Acute Migraine Drugs Sales by Type (2017-2027)
7.1.2 Europe Acute Migraine Drugs Revenue by Type (2017-2027)
7.2 Europe Acute Migraine Drugs Market Size by Application
7.2.1 Europe Acute Migraine Drugs Sales by Application (2017-2027)
7.2.2 Europe Acute Migraine Drugs Revenue by Application (2017-2027)
7.3 Europe Acute Migraine Drugs Market Size by Country
7.3.1 Europe Acute Migraine Drugs Sales by Country (2017-2027)
7.3.2 Europe Acute Migraine Drugs Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Acute Migraine Drugs Market Size by Type
8.1.1 Asia Pacific Acute Migraine Drugs Sales by Type (2018-2027)
8.1.2 Asia Pacific Acute Migraine Drugs Revenue by Type (2018-2027)
8.2 Asia Pacific Acute Migraine Drugs Market Size by Application
8.2.1 Asia Pacific Acute Migraine Drugs Sales by Application (2018-2027)
8.2.2 Asia Pacific Acute Migraine Drugs Revenue by Application (2018-2027)
8.3 Asia Pacific Acute Migraine Drugs Market Size by Region
8.3.1 Asia Pacific Acute Migraine Drugs Sales by Region (2018-2027)
8.3.2 Asia Pacific Acute Migraine Drugs Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Acute Migraine Drugs Market Size by Type
9.1.1 Latin America Acute Migraine Drugs Sales by Type (2019-2027)
9.1.2 Latin America Acute Migraine Drugs Revenue by Type (2019-2027)
9.2 Latin America Acute Migraine Drugs Market Size by Application
9.2.1 Latin America Acute Migraine Drugs Sales by Application (2019-2027)
9.2.2 Latin America Acute Migraine Drugs Revenue by Application (2019-2027)
9.3 Latin America Acute Migraine Drugs Market Size by Country
9.3.1 Latin America Acute Migraine Drugs Sales by Country (2019-2027)
9.3.2 Latin America Acute Migraine Drugs Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Acute Migraine Drugs Market Size by Type
6.1.1 Middle East and Africa Acute Migraine Drugs Sales by Type (2016-2027)
6.1.2 Middle East and Africa Acute Migraine Drugs Revenue by Type (2016-2027)
6.2 Middle East and Africa Acute Migraine Drugs Market Size by Application
6.2.1 Middle East and Africa Acute Migraine Drugs Sales by Application (2016-2027)
6.2.2 Middle East and Africa Acute Migraine Drugs Revenue by Application (2016-2027)
6.3 Middle East and Africa Acute Migraine Drugs Market Size by Country
6.3.1 Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2027)
6.3.2 Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK Acute Migraine Drugs Product Description
11.1.5 GSK Related Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Teva Acute Migraine Drugs Product Description
11.2.5 Teva Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Pfizer Acute Migraine Drugs Product Description
11.3.5 Pfizer Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Novartis Acute Migraine Drugs Product Description
11.4.5 Novartis Related Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Corporation Information
11.5.2 Sun Pharma Overview
11.5.3 Sun Pharma Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Sun Pharma Acute Migraine Drugs Product Description
11.5.5 Sun Pharma Related Developments
11.6 Grunenthal
11.6.1 Grunenthal Corporation Information
11.6.2 Grunenthal Overview
11.6.3 Grunenthal Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Grunenthal Acute Migraine Drugs Product Description
11.6.5 Grunenthal Related Developments
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Corporation Information
11.7.2 Endo Pharmaceuticals Overview
11.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Endo Pharmaceuticals Acute Migraine Drugs Product Description
11.7.5 Endo Pharmaceuticals Related Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Overview
11.8.3 Merck Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Merck Acute Migraine Drugs Product Description
11.8.5 Merck Related Developments
11.9 J & J
11.9.1 J & J Corporation Information
11.9.2 J & J Overview
11.9.3 J & J Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 J & J Acute Migraine Drugs Product Description
11.9.5 J & J Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK Acute Migraine Drugs Product Description
11.1.5 GSK Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Acute Migraine Drugs Value Chain Analysis
12.2 Acute Migraine Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Acute Migraine Drugs Production Mode & Process
12.4 Acute Migraine Drugs Sales and Marketing
12.4.1 Acute Migraine Drugs Sales Channels
12.4.2 Acute Migraine Drugs Distributors
12.5 Acute Migraine Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Acute Migraine Drugs Industry Trends
13.2 Acute Migraine Drugs Market Drivers
13.3 Acute Migraine Drugs Market Challenges
13.4 Acute Migraine Drugs Market Restraints
14 Key Findings in The Global Acute Migraine Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Acute Migraine Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Triptans
    Table 3. Major Manufacturers of NSAIDs
    Table 4. Major Manufacturers of Others
    Table 5. Global Acute Migraine Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Acute Migraine Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit)
    Table 8. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021)
    Table 9. Global Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit)
    Table 10. Global Acute Migraine Drugs Sales Market Share by Region (2022-2027)
    Table 11. Global Acute Migraine Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 12. Global Acute Migraine Drugs Revenue Market Share by Region (2016-2021)
    Table 13. Global Acute Migraine Drugs Revenue by Region (2022-2027) & (US$ Million)
    Table 14. Global Acute Migraine Drugs Revenue Market Share by Region (2022-2027)
    Table 15. Global Acute Migraine Drugs Sales by Manufacturers (2016-2021) & (K Unit)
    Table 16. Global Acute Migraine Drugs Sales Share by Manufacturers (2016-2021)
    Table 17. Global Acute Migraine Drugs Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 18. Global Acute Migraine Drugs Revenue Share by Manufacturers (2016-2021)
    Table 19. Acute Migraine Drugs Price by Manufacturers 2016-2021 (USD/Unit)
    Table 20. Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2020)
    Table 22. Acute Migraine Drugs Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Acute Migraine Drugs Product Offered
    Table 24. Date of Manufacturers Enter into Acute Migraine Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
    Table 27. Global Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
    Table 28. Global Acute Migraine Drugs Sales Share by Type (2016-2021)
    Table 29. Global Acute Migraine Drugs Sales Share by Type (2022-2027)
    Table 30. Global Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 31. Global Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 32. Global Acute Migraine Drugs Revenue Share by Type (2016-2021)
    Table 33. Global Acute Migraine Drugs Revenue Share by Type (2022-2027)
    Table 34. Acute Migraine Drugs Price by Type (2016-2021) & (USD/Unit)
    Table 35. Global Acute Migraine Drugs Price Forecast by Type (2022-2027) & (USD/Unit)
    Table 36. Global Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
    Table 37. Global Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
    Table 38. Global Acute Migraine Drugs Sales Share by Application (2016-2021)
    Table 39. Global Acute Migraine Drugs Sales Share by Application (2022-2027)
    Table 40. Global Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 41. Global Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 42. Global Acute Migraine Drugs Revenue Share by Application (2016-2021)
    Table 43. Global Acute Migraine Drugs Revenue Share by Application (2022-2027)
    Table 44. Acute Migraine Drugs Price by Application (2016-2021) & (USD/Unit)
    Table 45. Global Acute Migraine Drugs Price Forecast by Application (2022-2027) & (USD/Unit)
    Table 46. North America Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
    Table 47. North America Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
    Table 48. North America Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 49. North America Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 50. North America Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
    Table 51. North America Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
    Table 52. North America Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 53. North America Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 54. North America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
    Table 55. North America Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit)
    Table 56. North America Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 57. North America Acute Migraine Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 58. Europe Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
    Table 59. Europe Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
    Table 60. Europe Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 61. Europe Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 62. Europe Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
    Table 63. Europe Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
    Table 64. Europe Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 65. Europe Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 66. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
    Table 67. Europe Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit)
    Table 68. Europe Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 69. Europe Acute Migraine Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 70. Asia Pacific Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
    Table 71. Asia Pacific Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
    Table 72. Asia Pacific Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 73. Asia Pacific Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 74. Asia Pacific Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
    Table 75. Asia Pacific Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
    Table 76. Asia Pacific Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 77. Asia Pacific Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 78. Asia Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit)
    Table 79. Asia Pacific Acute Migraine Drugs Sales by Region (2022-2027) & (K Unit)
    Table 80. Asia Pacific Acute Migraine Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 81. Asia Pacific Acute Migraine Drugs Revenue by Region (2022-2027) & (US$ Million)
    Table 82. Latin America Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
    Table 83. Latin America Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
    Table 84. Latin America Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 85. Latin America Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 86. Latin America Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
    Table 87. Latin America Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
    Table 88. Latin America Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 89. Latin America Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 90. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
    Table 91. Latin America Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit)
    Table 92. Latin America Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 93. Latin America Acute Migraine Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 94. Middle East and Africa Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit)
    Table 95. Middle East and Africa Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit)
    Table 96. Middle East and Africa Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 97. Middle East and Africa Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 98. Middle East and Africa Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit)
    Table 99. Middle East and Africa Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit)
    Table 100. Middle East and Africa Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 101. Middle East and Africa Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 102. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
    Table 103. Middle East and Africa Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit)
    Table 104. Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 105. Middle East and Africa Acute Migraine Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 106. GSK Corporation Information
    Table 107. GSK Description and Major Businesses
    Table 108. GSK Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 109. GSK Acute Migraine Drugs Product
    Table 110. GSK Recent Developments
    Table 111. Teva Corporation Information
    Table 112. Teva Description and Major Businesses
    Table 113. Teva Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 114. Teva Acute Migraine Drugs Product
    Table 115. Teva Recent Developments
    Table 116. Pfizer Corporation Information
    Table 117. Pfizer Description and Major Businesses
    Table 118. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 119. Pfizer Acute Migraine Drugs Product
    Table 120. Pfizer Recent Developments
    Table 121. Novartis Corporation Information
    Table 122. Novartis Description and Major Businesses
    Table 123. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 124. Novartis Acute Migraine Drugs Product
    Table 125. Novartis Recent Developments
    Table 126. Sun Pharma Corporation Information
    Table 127. Sun Pharma Description and Major Businesses
    Table 128. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 129. Sun Pharma Acute Migraine Drugs Product
    Table 130. Sun Pharma Recent Developments
    Table 131. Grunenthal Corporation Information
    Table 132. Grunenthal Description and Major Businesses
    Table 133. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 134. Grunenthal Acute Migraine Drugs Product
    Table 135. Grunenthal Recent Developments
    Table 136. Endo Pharmaceuticals Corporation Information
    Table 137. Endo Pharmaceuticals Description and Major Businesses
    Table 138. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 139. Endo Pharmaceuticals Acute Migraine Drugs Product
    Table 140. Endo Pharmaceuticals Recent Developments
    Table 141. Merck Corporation Information
    Table 142. Merck Description and Major Businesses
    Table 143. Merck Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 144. Merck Acute Migraine Drugs Product
    Table 145. Merck Recent Developments
    Table 146. J & J Corporation Information
    Table 147. J & J Description and Major Businesses
    Table 148. J & J Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 149. J & J Acute Migraine Drugs Product
    Table 150. J & J Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Acute Migraine Drugs Distributors List
    Table 154. Acute Migraine Drugs Customers List
    Table 155. Acute Migraine Drugs Market Trends
    Table 156. Acute Migraine Drugs Market Drivers
    Table 157. Acute Migraine Drugs Market Challenges
    Table 158. Acute Migraine Drugs Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acute Migraine Drugs Product Picture
    Figure 2. Global Acute Migraine Drugs Market Share by Type in 2020 & 2027
    Figure 3. Triptans Product Picture
    Figure 4. NSAIDs Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Acute Migraine Drugs Sales Market Share by Application in 2020 & 2027
    Figure 7. Hospital Pharmacies
    Figure 8. Drug Stores
    Figure 9. Acute Migraine Drugs Report Years Considered
    Figure 10. Global Acute Migraine Drugs Sales 2016-2027 (K Unit)
    Figure 11. Global Acute Migraine Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Acute Migraine Drugs Revenue 2016-2027 (US$ Million)
    Figure 13. Global Acute Migraine Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 14. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021)
    Figure 15. Global Acute Migraine Drugs Sales Market Share by Region (2022-2027)
    Figure 16. North America Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit)
    Figure 17. North America Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 18. Europe Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit)
    Figure 19. Europe Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 20. Asia-Pacific Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit)
    Figure 21. Asia-Pacific Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 22. Latin America Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit)
    Figure 23. Latin America Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 24. Middle East & Africa Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit)
    Figure 25. Middle East & Africa Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 26. The Top 10 and Top 5 Players Market Share by Acute Migraine Drugs Sales in 2020
    Figure 27. The Top 10 and Top 5 Players Market Share by Acute Migraine Drugs Revenue in 2020
    Figure 28. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 29. Global Acute Migraine Drugs Sales Market Share by Type (2016-2027)
    Figure 30. Global Acute Migraine Drugs Revenue Market Share by Type (2016-2027)
    Figure 31. Global Acute Migraine Drugs Sales Market Share by Application (2016-2027)
    Figure 32. Global Acute Migraine Drugs Revenue Market Share by Application (2016-2027)
    Figure 33. North America Acute Migraine Drugs Sales Market Share by Type (2016-2027)
    Figure 34. North America Acute Migraine Drugs Revenue Market Share by Type (2016-2027)
    Figure 35. North America Acute Migraine Drugs Sales Market Share by Application (2016-2027)
    Figure 36. North America Acute Migraine Drugs Revenue Market Share by Application (2016-2027)
    Figure 37. North America Acute Migraine Drugs Sales Share by Country (2016-2027)
    Figure 38. North America Acute Migraine Drugs Revenue Share by Country (2016-2027)
    Figure 39. U.S. Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 40. Canada Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 41. Europe Acute Migraine Drugs Sales Market Share by Type (2016-2027)
    Figure 42. Europe Acute Migraine Drugs Revenue Market Share by Type (2016-2027)
    Figure 43. Europe Acute Migraine Drugs Sales Market Share by Application (2016-2027)
    Figure 44. Europe Acute Migraine Drugs Revenue Market Share by Application (2016-2027)
    Figure 45. Europe Acute Migraine Drugs Sales Share by Country (2016-2027)
    Figure 46. Europe Acute Migraine Drugs Revenue Share by Country (2016-2027)
    Figure 47. Germany Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 48. France Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 49. U.K. Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 50. Italy Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 51. Russia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 52. Asia Pacific Acute Migraine Drugs Sales Market Share by Type (2016-2027)
    Figure 53. Asia Pacific Acute Migraine Drugs Revenue Market Share by Type (2016-2027)
    Figure 54. Asia Pacific Acute Migraine Drugs Sales Market Share by Application (2016-2027)
    Figure 55. Asia Pacific Acute Migraine Drugs Revenue Market Share by Application (2016-2027)
    Figure 56. Asia Pacific Acute Migraine Drugs Sales Share by Region (2016-2027)
    Figure 57. Asia Pacific Acute Migraine Drugs Revenue Share by Region (2016-2027)
    Figure 58. China Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 59. Japan Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 60. South Korea Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 61. India Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 62. Australia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 63. Taiwan Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 64. Indonesia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 65. Thailand Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 66. Malaysia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 67. Philippines Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 68. Latin America Acute Migraine Drugs Sales Market Share by Type (2016-2027)
    Figure 69. Latin America Acute Migraine Drugs Revenue Market Share by Type (2016-2027)
    Figure 70. Latin America Acute Migraine Drugs Sales Market Share by Application (2016-2027)
    Figure 71. Latin America Acute Migraine Drugs Revenue Market Share by Application (2016-2027)
    Figure 72. Latin America Acute Migraine Drugs Sales Share by Country (2016-2027)
    Figure 73. Latin America Acute Migraine Drugs Revenue Share by Country (2016-2027)
    Figure 74. Mexico Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 75. Brazil Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 76. Argentina Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 77. Middle East and Africa Acute Migraine Drugs Sales Market Share by Type (2016-2027)
    Figure 78. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Type (2016-2027)
    Figure 79. Middle East and Africa Acute Migraine Drugs Sales Market Share by Application (2016-2027)
    Figure 80. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Application (2016-2027)
    Figure 81. Middle East and Africa Acute Migraine Drugs Sales Share by Country (2016-2027)
    Figure 82. Middle East and Africa Acute Migraine Drugs Revenue Share by Country (2016-2027)
    Figure 83. Turkey Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 84. Saudi Arabia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 85. U.A.E Acute Migraine Drugs Revenue (2016-2027) & (US$ Million)
    Figure 86. Acute Migraine Drugs Value Chain
    Figure 87. Acute Migraine Drugs Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global Postoperative Pain Management Market Size Status and Forecast 2021 2027
Global Postoperative Pain Management Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-29X5898
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Non Opioid Pain Treatment Market Size Status and Forecast 2021 2027
Global Non-Opioid Pain Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-37U5878
Sat Jul 17 00:00:00 UTC 2021

Add to Cart

Global Ketorolac Market Size Status and Forecast 2021 2027
Global Ketorolac Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-36L5761
Thu Jul 15 00:00:00 UTC 2021

Add to Cart

Global Pain Relievers Market Size Status and Forecast 2021 2027
Global Pain Relievers Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-15V5975
Thu Jul 15 00:00:00 UTC 2021

Add to Cart